A share price of AIM ImmunoTech Inc [AIM] is currently trading at $0.44, down -0.83%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AIM shares have gain 17.33% over the last week, with a monthly amount glided 5.36%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 25, March 2024, AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research. In a post published today on Yahoo Finance, Data demonstrate compelling evidence of the immune-stimulatory properties linked to TLR-3 activation through Ampligen.
From an analyst’s perspective:
AIM ImmunoTech Inc experienced fluctuations in its stock price throughout the past year between $0.32 and $0.75. AIM ImmunoTech Inc [AMEX: AIM] shares were valued at $0.44 at the most recent close of the market.
Analyzing the AIM fundamentals
Trailing Twelve Months sales for AIM ImmunoTech Inc [AMEX:AIM] were 0.19M which represents 119.05% growth. Gross Profit Margin for this corporation currently stands at -102.53% with Operating Profit Margin at -119.83%, Pretax Profit Margin comes in at -107.64%, and Net Profit Margin reading is -102.94%. To continue investigating profitability, this company’s Return on Assets is posted at -0.71, Equity is -0.63 and Total Capital is -1.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4170 points at the first support level, and at 0.3940 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4760, and for the 2nd resistance point, it is at 0.5120.
AIM ImmunoTech Inc [AIM] reported earnings per share of -$0.16 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.11/share, meaning a difference of -$0.05 and a surprise factor of -45.50%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.1 per share as compared to estimates of -$0.11 per share, a difference of $0.01 representing a surprise of 9.10%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for AIM ImmunoTech Inc [AMEX:AIM] is 4.82. Also, the Quick Ratio is 4.82, while the Cash Ratio stands at 3.24. Considering the valuation of this stock, the price to sales ratio is 113.10, the price to book ratio is 0.98.
Transactions by insiders
Recent insider trading involved BRYAN NANCY, Director, that happened on Mar 21 ’24 when 38462.0 shares were purchased. Director, APPELROUTH STEWART completed a deal on Mar 15 ’24 to buy 90910.0 shares. Meanwhile, CEO & President Equels Thomas K bought 75758.0 shares on Mar 15 ’24.
